In vitro and in vivo studies showed that activation of the ACE/Ang II/ angiotensin II type 1 receptor (ATR1) axis promotes cancer cell proliferation, invasion, angiogenesis and reduced immunosurveillance [9,10,11]. This evidence concerns the gene ACE and cancer.